Systemic treatment and targeted therapy in patients with advanced hepatocellular carcinoma

BACKGROUND: Advanced hepatocellular carcinoma (HCC) is a malignancy of global importance: it is the sixth most common cancer and the third most common cause of cancer-related mortality worldwide. Despite decades of efforts by many investigators, systemic chemotherapy or hormone therapy has failed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Tazi, El Mehdi, Essadi, Ismail, M’rabti, Hind, Touyar, Anass, Errihani, PR Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3336907/
https://www.ncbi.nlm.nih.gov/pubmed/22540086
http://dx.doi.org/10.4297/najms.2011.3167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3336907/
https://www.ncbi.nlm.nih.gov/pubmed/22540086
http://dx.doi.org/10.4297/najms.2011.3167

Ejemplares similares